RGD-荧光近红外750
Ex (nm) | 757 | Em (nm) | 779 |
分子量 | ~1600 | 溶剂 | DMSO |
存储条件 | 在零下15度以下保存, 避免光照 |
产品基本信息
产品名称:RGD-荧光近红外750
储存条件:-15℃避光防潮
保质期:24个月
产品物理化学光谱特性
分子量:~1600
溶剂:DMSO
激发波长(nm):757
发射波长(nm):779
产品介绍
近红外荧光光学成像(又称活体成像)是一种在分子水平上研究小动物疾病的技术。水和生物组织在近红外(650-900纳米)中具有小的吸光度和自荧光,从而允许有效的光子进出组织,且组织内散射较低。通过这个近红外光线,生理上丰富的分子如血红蛋白、氧血红蛋白和脱氧血红蛋白对光的吸收也降到低。具有生物相容性荧光剂的活体成像系统正在开发和优化,以用于近红外光谱区域-确保大的光穿透和高的灵敏度。细胞粘附分子整合素参与多种肿瘤的血管生成和转移。整合素在活化的内皮细胞和快速生长的实体瘤细胞中明显上调,而在静止的血管和大多数正常组织中表达低。 iFluor 750标记的单体精氨酸-甘氨酸-天冬氨酸(RGD)肽c(RGDyK)专门针对细胞培养和活体内的整联蛋白。 iFluor 750-c(RGDyK)的体内功效取决于许多因素,包括受体亲和力,特异性,分子大小,总分子电荷,亲水性和代谢稳定性。
参考文献
99mTc-Glu-c(RGDyK)-Bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography
Authors: Ji T, Gao S, Liu Z, Xing H, Zhao G, Ma Q.
Journal: J Nucl Med (2016): 1196
In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide
Authors: Chen Y, Zhang W, Huang Y, Gao F, Fang X.
Journal: PLoS One (2016): e0149952
Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization
Authors: P and ya DN, Hantgan R, Budzevich MM, Kock ND, Morse DL, Batista I, Mintz A, Li KC, Wadas TJ.
Journal: Theranostics (2016): 698
c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
Authors: Huang Y, Liu W, Gao F, Fang X, Chen Y.
Journal: Int J Nanomedicine (2016): 1629
Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor
Authors: Chen Y, Zhang W, Huang Y, Gao F, Fang X.
Journal: Int J Nanomedicine (2015): 4863
Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles
Authors: Gao Y, Zhou Y, Zhao L, Zhang C, Li Y, Li J, Li X, Liu Y.
Journal: Acta Biomater (2015): 127
Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors
Authors: Oxboel J, Br and t-Larsen M, Schjoeth-Eskesen C, Myschetzky R, El-Ali HH, Madsen J, Kjaer A.
Journal: Nucl Med Biol (2014): 259
The C(RgdyK)-conjugated Fe3O4 nanoparticles with high drug load for dual-targeting integrin alpha(v)beta3-expressing cancer cells
Authors: Guo L, Ding W, Zheng LM.
Journal: J Nanosci Nanotechnol (2014): 4858
Design and biological evaluation of (9)(9)mTc-N(2)S(2)-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing alpha(v)beta(3) integrins
Authors: Ocampo-Garcia BE, Santos-Cuevas CL, De Leon-Rodriguez LM, Garcia-Becerra R, Ordaz-Rosado D, Luna-Guitierrez MA, Jimenez-Mancilla NP, Romero-Pina ME, Ferro-Flores G.
Journal: Nucl Med Biol (2013): 481
Quantitative positron emission tomography imaging of angiogenesis in rats with forelimb ischemia using (68)Ga-NOTA-c(RGDyK)
Authors: Kim JH, Kim YH, Kim YJ, Yang BY, Jeong JM, Youn H, Lee DS, Lee JS.
Journal: Angiogenesis (2013): 837